Clinical Research Directory
Browse clinical research sites, groups, and studies.
B-amyloid as a Marker for GBM Bioimaging
Sponsor: Universidad Central del Caribe
Summary
This project is aimed at improvement of glioblastoma (GBM) diagnostic strategies for discrimination of tumor progression and chemo- and radiotherapeutic treatment-related changes in brain tissue. The study will elucidate the diagnostic value of PET imaging with use of amyloid-β radioisotope tracer Amyvid (Florbetapir F18) for GBM. The results of the study will provide data for development of new approach for GBM diagnostics.
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
3
Start Date
2024-07
Completion Date
2026-07
Last Updated
2023-12-21
Healthy Volunteers
No
Conditions
Interventions
Amyvid, Intravenous Solution
Amyvid 370MBq (10mCi) absorbed dose 7mSv of will be introduced intravenously and 30-50 minutes after the PET images will be acquired.
Locations (2)
Central University of the Caribbean (UCC)
Bayamón, PR, Puerto Rico
University of Puerto Rico, Medical Science Campus
San Juan, Puerto Rico